Takeda Canada Inc. v. Apotek Inc., 2023 FC 63
Jurisdiction | Federal Jurisdiction (Canada) |
Court | Federal Court (Canada) |
Citation | 2023 FC 63 |
Date | 13 January 2023 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
1 practice notes
-
Federal Court Dismisses Takeda's Motion To Consolidate Two Dexlansoprazole PMNOC Actions Against Apotex
...under the Patented Medicines (Notice of Compliance) Regulations (PMNOC Regulations) against Apotex: Takeda Canada Inc v Apotex Inc, 2023 FC 63. Both actions involve Takeda's dexlansoprazole product, DEXILANT, and one Abbreviated New Drug Submission (ANDS) filed by There are eight patents li......
1 firm's commentaries
-
Federal Court Dismisses Takeda's Motion To Consolidate Two Dexlansoprazole PMNOC Actions Against Apotex
...under the Patented Medicines (Notice of Compliance) Regulations (PMNOC Regulations) against Apotex: Takeda Canada Inc v Apotex Inc, 2023 FC 63. Both actions involve Takeda's dexlansoprazole product, DEXILANT, and one Abbreviated New Drug Submission (ANDS) filed by There are eight patents li......